Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
New Studies Highlight JAK Inhibitors’ Power as AD Treatment
Reducing Polycythemia Vera–Associated Thrombotic Risk Through Iron Regulation
Financial, Housing, Food Insecurity Raises Risk of Hospital, ED Visits
ANTHEM-UC: Icotrokinra (JNJ-2113) Shows Promise for Ulcerative Colitis